Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Kuwait.
Campus
Campus

Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs

Insights from Prof. Timothy Baily on new Real-world evidence in deliver G study and the implications of adding Toujeo® to people with T2D inadequately controlled on GLP-RAs.

Related articles
Advancing Therapy with iGlarLixi: Differentiation from other complex regimens
  • Diabetes

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

Read article
Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens
  • Diabetes

Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

Read article
The value of Time-in-range
  • Diabetes

The value of Time-in-range

Read article
MAT-BH-2100740/V1/October 2021